Seroatlas · Human Serome Atlas

NDUFB9

NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9

Also known as: B22, LYRM3, NDUB9_HUMAN, UQOR22

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9Y6M9
Gene
NDUFB9
Ensembl
ENSG00000147684
Chromosome
8
Canonical length
179 aa
Protein class
Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins
Subcellular location
Mitochondria

OverviewNCBI Gene

The protein encoded by this gene is a subunit of the mitochondrial oxidative phosphorylation complex I (nicotinamide adenine dinucleotide: ubiquinone oxidoreductase). Complex I is localized to the inner mitochondrial membrane and functions to dehydrogenate nicotinamide adenine dinucleotide and to shuttle electrons to coenzyme Q. Complex I deficiency is the most common defect found in oxidative phosphorylation disorders and results in a range of conditions, including lethal neonatal disease, hypertrophic cardiomyopathy, liver disease, and adult-onset neurodegenerative disorders. Pseudogenes of this gene are found on chromosomes five, seven and eight. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2015]

Canonical amino-acid sequenceUniProt

179 residues, UniProt reviewed canonical sequence.

>Q9Y6M9|NDUFB9
     1  MAFLASGPYL THQQKVLRLY KRALRHLESW CVQRDKYRYF ACLMRARFEE HKNEKDMAKA
    61  TQLLKEAEEE FWYRQHPQPY IFPDSPGGTS YERYDCYKVP EWCLDDWHPS EKAMYPDYFA
   121  KREQWKKLRR ESWEREVKQL QEETPPGGPL TEALPPARKE GDLPPLWWYI VTRPRERPM

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against NDUFB9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Other membrane
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.4
Highest tissue expression
1,386 nTPM

Expression across tissuesHPA

Tissue

  • tongue: 1,386 nTPM
  • skeletal muscle: 1,287 nTPM
  • heart muscle: 775 nTPM
  • amygdala: 497 nTPM
  • midbrain: 469 nTPM
  • cerebral cortex: 453 nTPM

Single-cell type

  • late spermatids: 1,281 nCPM
  • gastric progenitor cells: 1,028 nCPM
  • parietal cells: 1,002 nCPM
  • esophageal basal cells: 813 nCPM
  • esophageal suprabasal cells: 780 nCPM
  • late primary spermatocytes: 722 nCPM

Immune cell

  • T-reg: 347 nTPM
  • total PBMC: 346 nTPM
  • basophil: 303 nTPM
  • memory CD4 T-cell: 277 nTPM
  • naive CD4 T-cell: 270 nTPM
  • memory B-cell: 262 nTPM

Brain region

  • cerebral cortex: 202 nTPM
  • hypothalamus: 190 nTPM
  • thalamus: 190 nTPM
  • pons: 175 nTPM
  • cerebellum: 174 nTPM
  • medulla oblongata: 171 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about NDUFB9.

Disease | AllUniProt

Conditions NDUFB9 is implicated in, by any mechanism.

Disease | GeneticClinVar

1 pathogenic / likely-pathogenic of 128 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.04
gnomAD pLI
0
gnomAD missense Z
0
DepMap mean gene effect
-0.57
DepMap dependency class
common

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 13% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of NDUFB9 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads NDUFB9 as an antibody target. Whether an autoantibody or antibody against NDUFB9 could matter depends on whether native NDUFB9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

NDUFB9 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label NDUFB9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/NDUFB9. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...